These are bad times for generic drug makers and their regulators.

Some generic drug makers fear that the big companies will crush them.

And just days ago, he pushed for a way to assist generic drug makers.

In any event, money is at the heart of the generic makers' strategic shift.

Needless to say, things were easier for generic makers back then.

Not that the generic drug makers will get the entire pinata.

"Novopharm is the only generic drug maker to win on this issue."

The impact on India's large generic drug makers could be muted.

The company has been fighting Ivax and other generic drug makers in court since 1997.

He prefers generic drug makers that do not fight Federal regulators.